PubRank

Masahisa Katsuno

Author PubWeight™ 80.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005 3.65
2 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat Med 2005 3.19
3 Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 2009 2.26
4 Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol 2005 1.59
5 Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. Sci Rep 2012 1.58
6 Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain 2006 1.57
7 Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1. J Biol Chem 2007 1.57
8 Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein. J Neurosci 2003 1.54
9 Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet 2004 1.52
10 TDP-43 depletion induces neuronal cell damage through dysregulation of Rho family GTPases. J Biol Chem 2009 1.44
11 Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol 2009 1.43
12 Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. Nat Med 2012 1.41
13 CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. J Neurosci 2007 1.34
14 Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain 2005 1.33
15 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. Hum Mol Genet 2008 1.25
16 Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein. J Mol Med (Berl) 2006 1.16
17 Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice. J Neurosci 2011 1.14
18 Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain 2013 1.05
19 CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA. Brain 2007 1.04
20 Correlation between pyramidal tract degeneration and widespread white matter involvement in amyotrophic lateral sclerosis: a study with tractography and diffusion-tensor imaging. Amyotroph Lateral Scler 2009 1.03
21 Macroautophagy is regulated by the UPR-mediator CHOP and accentuates the phenotype of SBMA mice. PLoS Genet 2011 1.02
22 Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophy. PLoS One 2010 1.02
23 Clinicopathological features of acute autonomic and sensory neuropathy. Brain 2010 1.00
24 Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies. Neurobiol Dis 2011 0.99
25 Walking capacity evaluated by the 6-minute walk test in spinal and bulbar muscular atrophy. Muscle Nerve 2008 0.97
26 Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG). Ann N Y Acad Sci 2006 0.96
27 Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy. Mol Med 2012 0.96
28 p62/SQSTM1 differentially removes the toxic mutant androgen receptor via autophagy and inclusion formation in a spinal and bulbar muscular atrophy mouse model. J Neurosci 2013 0.95
29 Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy. Hum Mol Genet 2013 0.94
30 dnc-1/dynactin 1 knockdown disrupts transport of autophagosomes and induces motor neuron degeneration. PLoS One 2013 0.94
31 Geranylgeranylacetone ameliorates ischemic acute renal failure via induction of Hsp70. Kidney Int 2005 0.93
32 Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjögren's syndrome. J Neurol Sci 2009 0.92
33 Neuronal intranuclear inclusion disease cases with leukoencephalopathy diagnosed via skin biopsy. J Neurol Neurosurg Psychiatry 2013 0.92
34 Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract. Nat Med 2012 0.91
35 Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. J Neurol Sci 2009 0.89
36 Disruption of axonal transport in motor neuron diseases. Int J Mol Sci 2012 0.89
37 Amyotrophic lateral sclerosis: an update on recent genetic insights. J Neurol 2013 0.89
38 Heat shock factor-1 influences pathological lesion distribution of polyglutamine-induced neurodegeneration. Nat Commun 2013 0.88
39 A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese. Hum Mol Genet 2011 0.86
40 Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy. Neurology 2013 0.85
41 FUS-regulated region- and cell-type-specific transcriptome is associated with cell selectivity in ALS/FTLD. Sci Rep 2013 0.85
42 Cortical and subcortical brain atrophy in Parkinson's disease with visual hallucination. Mov Disord 2013 0.85
43 Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Brain 2012 0.84
44 TSUNAMI: an antisense method to phenocopy splicing-associated diseases in animals. Genes Dev 2012 0.84
45 Gene expressions specifically detected in motor neurons (dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C) differentially correlate to pathologic markers in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 2007 0.84
46 Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker. Ann Neurol 2006 0.83
47 Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 2013 0.83
48 The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons. FEBS Open Bio 2013 0.83
49 Heat shock proteins in neurodegenerative diseases: pathogenic roles and therapeutic implications. Int J Hyperthermia 2009 0.83
50 Spatial distribution of nerve fiber pathology and vasculitis in microscopic polyangiitis-associated neuropathy. J Neuropathol Exp Neurol 2011 0.83
51 Dorfin ameliorates phenotypes in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurosci Res 2010 0.82
52 Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener 2014 0.81
53 Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA). Cell Tissue Res 2012 0.81
54 Demographic features of Japanese patients with sporadic inclusion body myositis: a single-center referral experience. Intern Med 2013 0.81
55 Gene expression profiling toward understanding of ALS pathogenesis. Ann N Y Acad Sci 2006 0.81
56 Genistein, a natural product derived from soybeans, ameliorates polyglutamine-mediated motor neuron disease. J Neurochem 2013 0.81
57 Antiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy. Endocrinology 2014 0.81
58 Differential, size-dependent sensory neuron involvement in the painful and ataxic forms of primary Sjögren's syndrome-associated neuropathy. J Neurol Sci 2012 0.80
59 Discrimination of spinal and bulbar muscular atrophy from amyotrophic lateral sclerosis using sensory nerve action potentials. Muscle Nerve 2012 0.80
60 Putaminal magnetic resonance imaging features at various magnetic field strengths in multiple system atrophy. Mov Disord 2010 0.79
61 RNP2 of RNA recognition motif 1 plays a central role in the aberrant modification of TDP-43. PLoS One 2013 0.79
62 c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis. PLoS One 2012 0.79
63 Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy. Int J Mol Sci 2009 0.78
64 Nonmyelinating Schwann cell involvement with well-preserved unmyelinated axons in Charcot-Marie-Tooth disease type 1A. J Neuropathol Exp Neurol 2007 0.78
65 Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation. J Neurol Neurosurg Psychiatry 2010 0.78
66 IgM MGUS anti-MAG neuropathy with predominant muscle weakness and extensive muscle atrophy. Muscle Nerve 2010 0.78
67 Sweet relief for Huntington disease. Nat Med 2004 0.78
68 Current status of treatment of spinal and bulbar muscular atrophy. Neural Plast 2012 0.78
69 Severe brain atrophy in the elderly as a risk factor for lower respiratory tract infection. Clin Interv Aging 2012 0.77
70 Morphological progression of myelin abnormalities in IgM-monoclonal gammopathy of undetermined significance anti-myelin-associated glycoprotein neuropathy. J Neuropathol Exp Neurol 2010 0.77
71 Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy. J Neurol 2011 0.77
72 [Molecular-targeted therapy for motor neuron disease]. Brain Nerve 2009 0.77
73 Head Lift Exercise Improves Swallowing Dysfunction in Spinal and Bulbar Muscular Atrophy. Eur Neurol 2015 0.77
74 Slowly progressive autonomic neuropathy with antiganglionic acetylcholine receptor antibody. J Neurol Neurosurg Psychiatry 2010 0.76
75 Dutasteride for spinal and bulbar muscular atrophy. Lancet Neurol 2011 0.76
76 The profile of motor unit number estimation (MUNE) in spinal and bulbar muscular atrophy. J Neurol Neurosurg Psychiatry 2009 0.76
77 Intravenous immunoglobulin therapy in proximal diabetic neuropathy. BMJ Case Rep 2009 0.75
78 Alcoholic Myelopathy and Nutritional Deficiency. Intern Med 2017 0.75
79 Impaired Pain Processing Correlates with Cognitive Impairment in Parkinson's Disease. Intern Med 2016 0.75
80 Progressive multifocal leukoencephalopathy with bilateral middle cerebellar peduncle lesions confirmed by repeated CSF-JC virus tests and coexistence of JC virus granule cell neuronopathy. Report of a case. Rinsho Shinkeigaku 2016 0.75
81 [67Ga scintigraphy as a therapeutic marker for spinal cord and muscular sarcoidosis: A case report]. Rinsho Shinkeigaku 2015 0.75
82 Expanding concept of clinical conditions and symptoms in multiple system atrophy. Rinsho Shinkeigaku 2016 0.75
83 Pathological background of subcortical hyperintensities on diffusion-weighted images in a case of neuronal intranuclear inclusion disease. Clin Neuropathol 2016 0.75
84 Gene Expression Profile of Inflammatory Myopathy with Malignancy is Similar to that of Dermatomyositis rather than Polymyositis. Intern Med 2016 0.75
85 [Development of the treatment for bulbospinal muscular atrophy]. Nihon Naika Gakkai Zasshi 2004 0.75
86 Cross-sectional and longitudinal analysis of an oxidative stress biomarker for spinal and bulbar muscular atrophy. Muscle Nerve 2012 0.75
87 Schwann cell involvement in the peripheral neuropathy of spinocerebellar ataxia type 3. Neuropathol Appl Neurobiol 2014 0.75
88 Polymorphism of transient axonal glycoprotein-1 in chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst 2011 0.75
89 [Disease-modifying therapy for spinal and bulbar muscular atrophy (SBMA)]. Brain Nerve 2012 0.75
90 [Treatment of spinal and bulbar muscular atrophy]. No To Shinkei 2004 0.75
91 Acute superficial sensory neuropathy with generalized anhidrosis, anosmia, and ageusia. Muscle Nerve 2011 0.75
92 [Motor neuron disease up-to date]. No To Shinkei 2005 0.75